Psychogenic Movement Disorders and Motor Conversion: A Roadmap for Collaboration Between Neurology and Psychiatry

Psychosomatics

Volumn 52, Issue 2, 2011, Pages 109-116

  Kranick, Sarah M ^a   Gorrindo, Tristan ^b   Hallett, Mark ^a  

^a NATIONAL INSTITUTE OF NEUROLOGICAL DISORDERS AND STROKE   (United States)

^b MASSACHUSETTS GENERAL HOSPITAL   (United States)

Author keywords

[No Author keywords available]

Indexed keywords

CITALOPRAM; PAROXETINE; VENLAFAXINE;

ACUPUNCTURE; ANXIETY DISORDER; ARTICLE; COGNITIVE THERAPY; COMORBIDITY; CONVERSION DISORDER; DIAGNOSTIC AND STATISTICAL MANUAL OF MENTAL DISORDERS; DISEASE CLASSIFICATION; FACTITIOUS DISEASE; HEALTH CARE DELIVERY; HUMAN; HYPNOSIS; MENTAL DISEASE; MOTOR DYSFUNCTION; NEUROLOGY; NOMENCLATURE; NUCLEAR MAGNETIC RESONANCE IMAGING; PHYSIOTHERAPY; PRACTICE GUIDELINE; PSYCHIATRIC DIAGNOSIS; PSYCHIATRIST; PSYCHIATRY; PSYCHOGENESIS; PSYCHOGENIC MOVEMENT DISORDER; COOPERATION; PATIENT CARE; PSYCHOLOGICAL ASPECT; PSYCHOMOTOR DISORDER; PUBLIC RELATIONS;

CONVERSION DISORDER; COOPERATIVE BEHAVIOR; HUMANS; INTERPROFESSIONAL RELATIONS; NEUROLOGY; PATIENT CARE TEAM; PSYCHIATRY; PSYCHOMOTOR DISORDERS; TERMINOLOGY AS TOPIC;

EID: 79960950512     PISSN: 00333182     EISSN: 15457206     Source Type: Journal    
DOI: 10.1016/j.psym.2010.12.017     Document Type: Article

References (51)

1. Jankovic J. Treatment of hyperkinetic movement disorders. Lancet Neurol 2009, 8:844-856.
2. Nowak D.A., Fink G.R. Psychogenic movement disorders: aetiology, phenomenology, neuroanatomical correlates and therapeutic approaches. Neuroimage 2009, 47:1015-1025.
3. Stern T.A., Rosenbaum J.F., Fava M., et al. Massachusetts General Hospital comprehensive clinical psychiatry 2008, Mosby/Elsevier, Philadelphia, PA. 1st edition.
4. Hallett M. Psychogenic movement disorders: A crisis for neurology. Curr Neurol Neurosci Rep 2006, 6:269-271.
5. Diagnostic and statistical manual of mental disorders: DSM-IV-TR 2000, American Psychiatric Association Task Force on DSM-IV, American Psychiatric Association, Washington, DC. 4th edition.
6. Fahn S., Jankovic J. Principles and practice of movement disorders 2007, Churchill Livingstone Elsevier, Philadelphia.
7. Feinstein A., Stergiopoulos V., Fine J., et al. Psychiatric outcome in patients with a psychogenic movement disorder: A prospective study. Neuropsychiat Neuropsychol Behav Neurol 2001, 14:169-176.
8. Hallett M. Physiology of psychogenic movement disorders. J Clin Neurosci 2010, 17:959-965.
9. Bowman E.S. Why conversion seizures should be classified as a dissociative disorder. Psychiatr Clin North Am 2006, 29:185-211. x.
10. Brown R.J., Cardena E., Nijenhuis E., et al. Should conversion disorder be reclassified as a dissociative disorder in DSM V?. Psychosomatics 2007, 48:369-378.
11. Binzer M., Andersen P.M., Kullgren G. Clinical characteristics of patients with motor disability due to conversion disorder: A prospective control group study. J Neurol Neurosurg Psychiatry 1997, 63:83-88.
12. Binzer M., Kullgren G. Motor conversion disorder. A prospective 2- to 5-year follow-up study. Psychosomatics 1998, 39:519-527.
13. Deuschl G., Koster B., Lucking C.H., et al. Diagnostic and pathophysiological aspects of psychogenic tremors. Mov Disord 1998, 13:294-302.
14. Factor S.A., Podskalny G.D., Molho E.S. Psychogenic movement disorders: frequency, clinical profile, and characteristics. J Neurol Neurosurg Psychiatry 1995, 59:406-412.
15. Jankovic J., Vuong K.D., Thomas M. Psychogenic tremor: long-term outcome. CNS Spectr 2006, 11:501-508.
16. Kim Y.J., Pakiam A.S., Lang A.E. Historical and clinical features of psychogenic tremor: a review of 70 cases. Can J Neurol Sci 1999, 26:190-195.
17. Lang A.E. Psychogenic dystonia: A review of 18 cases. Can J Neurol Sci 1995, 22:136-143.
18. Lang A.E., Koller W.C., Fahn S. Psychogenic parkinsonism. Arch Neurol 1995, 52:802-810.
19. Williams D.T., Ford B., Fahn S. Phenomenology and psychopathology related to psychogenic movement disorders. Adv Neurol 1995, 65:231-257.
20. Espay A.J., Goldenhar L.M., Voon V., et al. Opinions and clinical practices related to diagnosing and managing patients with psychogenic movement disorders: An international survey of movement disorder society members. Mov Disord 2009, 24:1366-1374.
21. Peckham E.L., Hallett M. Psychogenic movement disorders. Neurol Clin 2009, 27:801-819. vii.
22. Stone J., Smyth R., Carson A., et al. Systematic review of misdiagnosis of conversion symptoms and "hysteria". BMJ 2005, 331:989.
23. Krem M.M. Motor conversion disorders reviewed from a neuropsychiatric perspective. J Clin Psychiatry 2004, 65:783-790.
24. Reich S.G. Psychogenic movement disorders. Semin Neurol 2006, 26:289-296.
25. Kleinman A. The illness narratives: Suffering, healing, and the human condition 1989, 32. Basic Books, New York.
26. Stone J., Wojcik W., Durrance D., et al. What should we say to patients with symptoms unexplained by disease?. The "number needed to offend". BMJ 2002, 325:1449-1450.
27. Crimlisk H.L., Bhatia K., Cope H., et al. Slater revisited: Six-year follow-up study of patients with medically unexplained motor symptoms. BMJ 1998, 316:582-586.
28. Hinson V.K., Weinstein S., Bernard B., et al. Single-blind clinical trial of psychotherapy for treatment of psychogenic movement disorders. Parkinsonism Relat Disord 2006, 12:177-180.
29. Koller W., Lang A., Vetere-Overfield B., et al. Psychogenic tremors. Neurology 1989, 39:1094-1099.
30. Monday K., Jankovic J. Psychogenic myoclonus. Neurology 1993, 43:349-352.
31. Morgan J., Mir P., Mahapatra R., et al. Psychogenic parkinsonism: Clinical features of a large case series. Mov Disord 2004, 19:S345-S346.
32. Ranawaya R., Riley D., Lang A. Psychogenic dyskinesias in patients with organic movement disorders. Mov Disord 1990, 5:127-133.
33. Voon V., Lang A.E. Antidepressant treatment outcomes of psychogenic movement disorder. J Clin Psychiatry 2005, 66:1529-1534.
34. Kihlstrom J.F. Dissociative disorders. Annu Rev Clin Psychol 2005, 1:227-253.
35. Kroenke K. Efficacy of treatment for somatoform disorders: a review of randomized controlled trials. Psychosom Med 2007, 69:881-888.
36. Ruddy R., House A. Psychosocial interventions for conversion disorder. Cochrane Database Syst Rev 2005, CD005331.
37. Speckens A.E., van Hemert A.M., Spinhoven P., et al. Cognitive behavioral therapy for medically unexplained physical symptoms: a randomised controlled trial. BMJ 1995, 311:1328-1332.
38. LaFrance W.C., Friedman J.H. Cognitive behavioral therapy for psychogenic movement disorder. Mov Disord 2009, 24:1856-1857.
39. Rampello L., Raffaele R., Nicoletti G., et al. Hysterical neurosis of the conversion type: therapeutic activity of neuroleptics with different hyperprolactinemic potency. Neuropsychobiology 1996, 33:186-188.
40. Rosebush P., Mazurek M. The treatment of conversion disorder. Psychogenic movement disorders 2006, 343. Lippincott Williams and Wilkins, Philadelphia. M. Hallett, C.R. Cloninger, S. Fahn (Eds.).
41. Stone J., Sharpe M., Rothwell P.M., et al. The 12 year prognosis of unilateral functional weakness and sensory disturbance. J Neurol Neurosurg Psychiatry 2003, 74:591-596.
42. Thomas M., Vuong K.D., Jankovic J. Long-term prognosis of patients with psychogenic movement disorders. Parkinsonism Relat Disord 2006, 12:382-387.
43. Ness D. Physical therapy management for conversion disorder: case series. J Neurol Phys Ther 2007, 31:30-39.
44. Speed J. Behavioral management of conversion disorder: retrospective study. Arch Phys Med Rehabil 1996, 77:147-154.
45. Van Nuenen B.F., Wohlgemuth M., Wong Chung R.E., et al. Acupuncture for psychogenic movement disorders: Treatment or diagnostic tool?. Mov Disord 2007, 22:1353-1355.
46. Dafotakis M., Schonfeldt-Lecuona C., Fink G.R., et al. Psychogenic tremor. Fortschr Neurol Psychiatr 2008, 76:647-654.
47. Moene F.C., Spinhoven P., Hoogduin K.A., et al. A randomized controlled clinical trial of a hypnosis-based treatment for patients with conversion disorder, motor type. Int J Clin Exp Hypn 2003, 51:29-50.
48. Levy J., Thomas M. Biofeedback therapy for psychogenic movement disorders. Psychogenic Movement Disorders 2006, 343. Lippincott Williams and Wilkins, Philadelphia. M. Hallett, C.R. Cloninger, S. Fahn (Eds.).
49. Chastan N., Parain D., Verin E., et al. Psychogenic aphonia: spectacular recovery after motor cortex transcranial magnetic stimulation. J Neurol Neurosurg Psychiatry 2009, 80:94.
50. Lim E.C., Ong B.K., Seet R.C. Is there a place for placebo in management of psychogenic movement disorders?. Ann Acad Med Singapore 2007, 36:208-210.
51. Shamy M.C. The treatment of psychogenic movement disorders with suggestion is ethically justified. Mov Disord 2009, 25:260-264.